NCT07683091

Brief Summary

Plaintext The purpose of this study is to evaluate whether a personalized training protocol driven by machine learning can successfully reduce time-loss sports injuries and enhance athletic performance in elite athletes. During a 9-month competitive sports season, a group of elite athletes was divided into two training

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

June 27, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

9 months

First QC Date

June 27, 2026

Last Update Submit

June 27, 2026

Conditions

Keywords

Machine LearningInjury PreventionAthletic PerformanceElite AthletesSports BiomechanicsTraining Load Optimization

Outcome Measures

Primary Outcomes (1)

  • Changes in Sprint Performance Time

    Sprint performance will be assessed using electronic timing gates to record running times over a specific distance from a stationary start. Lower times indicate improved sprint performance. Measurements will be taken at baseline and at the conclusion of the training intervention period to evaluate the impact of the workload protocols.

    12 weeks

Study Arms (2)

Control Cohort

ACTIVE COMPARATOR

Elite adolescent sprinters who followed standard, predetermined high-performance athletic training protocols typical for competitive season preparation. This group received structured training volume and intensity matching standard athletic coaching guidelines, without any machine learning interventions or adaptive workload adjustments.

Behavioral: Adaptive Machine Learning Workload Optimization

Algorithmic Cohort

EXPERIMENTAL

Elite adolescent sprinters who received a personalized training protocol dynamically optimized by a machine learning algorithm. The framework evaluated individual biomechanical variables, morning heart rate variability (HRV), sleep quality, and physiological fatigue metrics to adjust training volume and intensity.

Behavioral: Adaptive Machine Learning Workload Optimization

Interventions

A personalized, data-driven training intervention where athletic workloads are dynamically adjusted based on predictive modeling. The protocol continuously tracks individual physiological markers, biomechanical data, and workload history to optimize training volume and intensity. This adaptive approach aims to maximize performance gains while minimizing the risk of overtraining and injury during the competitive season.

Algorithmic CohortControl Cohort

Eligibility Criteria

Age18 Years - 35 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Must be a competitive, elite-level or sub-elite track and field athlete specializing in short-to-mid distance running events.
  • Aged between 18 and 35 years old.
  • Actively participating in structured athletic training programs for at least 2 years prior to enrollment.
  • Free from any acute musculoskeletal injuries or medical conditions that prevent full participation in high-intensity training protocols.
  • Capable and willing to provide written informed consent to participate in the study.

You may not qualify if:

  • \. Concurrent use of performance-enhancing drugs or medications that influence metabolic or cardiovascular responses.
  • \. Inability to maintain consistent participation in the designated training protocols due to scheduling conflicts or travel.
  • \. Any underlying cardiovascular, respiratory, or systemic condition that creates a health risk during exhaustive exercise testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dr. Arefayne

Debre Berhan, Shewa, 445, Ethiopia

Location

M Dessye

Debre Berhan, Shewa, 445, Ethiopia

Location

MeSH Terms

Conditions

Athletic Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Dr. Arefayne M Dessye, PhD

    Debre Berhan Univeristy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A parallel-group randomized controlled trial design was utilized to compare two distinct high-performance training tracks over a 9-month competitive season. Elite athletes were randomly allocated into either the experimental arm (undergoing dynamic, machine learning-driven training load and biomechanical optimization) or the active control arm (undergoing traditional, structured high-performance athletic preparation). Both groups trained concurrently under monitored conditions to isolate the effects of the technology-driven protocol on injury incidence and performance markers.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 27, 2026

First Posted

July 6, 2026

Study Start

January 1, 2023

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

July 6, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared publicly to maintain the confidentiality of the elite athletes involved and to protect proprietary training protocols. Aggregated study results and statistical analyses will be available through academic publication.

Locations